SLAC Today is
available online at:
http://today.slac.stanford.edu
In this issue:
Opening the Door to a New Class of Diabetes Drugs—Robotically
symmetry: Donors Dream Big
McCallum-Turner Reviews SLAC's Facility Management
Monday - September 24, 2007 |
Opening the Door to a New Class of Diabetes Drugs—RoboticallyA team led by researchers from the University of California, San Diego, has determined the structure of a protein in cells that shows potential as a target for new drugs to treat diabetes. The study, published September 4 in the journal Proceedings of the National Academy of Sciences, described the structure of the protein, called MitoNEET, that was previously identified as a site where diabetes drugs could operate. The researchers say that MitoNEET has a novel three-dimensional structure that makes it a particularly interesting candidate for the design of innovative compounds that can bind to it. Herb Axelrod and Aina Cohen of the Stanford Synchrotron Radiation Laboratory (SSRL) collaborated with the UCSD researchers. All data used to determine the structure of MitoNEET were obtained using SSRL macromolecular crystallography beamlines 9-2 and 11-1, which employ state-of-the-art robotically operated sample handling systems. "This is the first time that a protein like this has ever been found," said Patricia Jennings, a professor in UCSD's department of Chemistry and Biochemistry who led the study along with Mark Paddock, a project scientist in UCSD's Physics department. "It is a brand new structure, a unique beast, which makes it an exciting target for structure-based drug design." Read related press release... |
||
symmetry:
|
McCallum-Turner Reviews SLAC's
|
Events (see all | submit)
Access (see all)
Announcements
|
| ||
<%
Response.AddHeader "Last-modified", getArticleDate()
'Response.AddHeader "Last-modified","Mon, 01 Sep 1997 01:03:33 GMT"
'Monday, December 06, 2010
%> View online at http://today.slac.stanford.edu/. |